Hetero Ring Is Six-membered Consisting Of One Nitrogen And Five Carbons Patents (Class 514/188)
-
Patent number: 5877171Abstract: The method of this invention is directed to a treatment of depression in men and women and to a treatment of pre-menstrual syndrome (PMS) in women by administering to a patient a therapeutically effective amount of chromium in a pharmaceutically acceptable form either alone or in conjunction with the administration of a standard antidepressant composition, such as a selective serotonin reuptake inhibitor composition. Chromium, preferably in the form of chromium picolinate, is administered to the patient at dosages in a preferred range of about 200 to about 500 micrograms chromium.Type: GrantFiled: July 28, 1997Date of Patent: March 2, 1999Inventor: Malcolm N. McLeod
-
Patent number: 5854266Abstract: Disclosed herein is an antimicrobial composition characterized by synergistic antibacterial efficacy against Gram-negative bacteria and comprising an antimicrobially effective amount of a pyrithione salt or pyrithione acid, and an alcohol, preferably an aromatic alcohol. Also disclosed is a method of imparting antimicrobial activity to a composition comprising water or an organic solvent which comprises adding thereto an antimicrobially effective amount of the above-described antimicrobial composition.Type: GrantFiled: March 10, 1997Date of Patent: December 29, 1998Assignee: Olin CorporationInventor: John D. Nelson, Jr.
-
Patent number: 5843936Abstract: A locally administrable topical pharmaceutical composition is provided for use in the prevention or treatment of skin conditions associated with hyperproliferation of keratinocytes and/or an immunologically mediated disorders, as psoriasis, atopic dermatitis, contact dermatitis, seborrheic dermatitis or actinic dermatitis. The composition contains a topical carrier and spirogermanium or a structurally related azaspirane.Type: GrantFiled: June 28, 1996Date of Patent: December 1, 1998Inventor: Lawrence R. Bernstein
-
Patent number: 5834199Abstract: Methods for selecting transition metal complexes (TMCs) that can modulate the translation of an mRNA by selectively cleaving a regulatory element of the mRNA are described. Included are in vitro, in situ, and/or in vivo methods. In addition, methods of identifying and characterizing mRNAs that contain regulatory elements which can be targeted by the TMCs of the present invention are also provided. Pharmaceutical compositions containing the TMCs of the present invention are also included.Type: GrantFiled: April 29, 1997Date of Patent: November 10, 1998Assignee: North Carolina State UniversityInventor: Elizabeth C. Theil
-
Patent number: 5834457Abstract: Familial amyotrophic lateral sclerosis (FALS)-associated mutant CuZnSODs, A4V and G93A, have been discovered to catalyze the generation of hydroxyl radical from hydrogen peroxide at higher rates than that of wild type CuZnSOD. The copper chelator diethyldithiocarbamate (DDC) has been found to inhibit both radical generation and SOD activity of mutant CuZnSODs A4V and G93A at DDC concentrations significantly lower than those required to inhibit wild type CuZnSOD enzyme. In a neural cell culture model of FALS, DDC reverses the effect of four FALS-associated mutants, but does not alter the survival of cells expressing only wild type CuZnSOD. Thus, radical formation may be modulated and ALS treated in subjects with a mutant CuZnSOD enzyme by the administration of copper chelating agents. Treatment can also be affected by the administration of radical scavenging agents, or the administration of expression inhibitors specific for the mutant genes.Type: GrantFiled: January 26, 1996Date of Patent: November 10, 1998Assignees: The Regents of the University of California, The Burnham InstituteInventors: Dale E. Bredesen, Joan S. Valentine, Martina Wiedau-Pazos, Joy J. Goto, Edith B. Gralla
-
Patent number: 5789401Abstract: A method for treating Type II diabetes by administering to an affected individual a combination of chromic tripicolinate and biotin at doses far beyond the nutritional requirements. The two compounds are administered orally or parenterally at in daily dosages which provide between 1,000 and 10,000 .mu.g of chromium and between 1 mg and 200 mg biotin.Type: GrantFiled: August 8, 1997Date of Patent: August 4, 1998Assignee: Nutrition 21Inventor: Mark F. McCarty
-
Patent number: 5780451Abstract: An enteral nutritional product for a person having ulcerative colitis contains in combination (a) an oil blend which contains eicosapentaenoic acid (20:5n3) and/or docosahexaenoic acid (22:6n3), and (b) a source of indigestible carbohydrate which is metabolized to short chain fatty acids by microorganisms present in the human colon. Preferably the nutritional product also contains one or more nutrients which act as antioxidants.Type: GrantFiled: April 1, 1994Date of Patent: July 14, 1998Assignee: Abbott LaboratoriesInventors: Stephen Joseph DeMichele, Keith Allen Garleb, John William McEwen, Martha Kay Fuller
-
Patent number: 5776960Abstract: Compositions comprising an ionene polymer and a pyrithione salt are disclosed which are synergistically effective compared to the respective components alone in controlling the growth of microorganisms in or on a material or medium. Methods to control the growth of microorganisms and prevent spoilage caused by microorganisms with the use of the compositions of the present invention are also disclosed.Type: GrantFiled: October 16, 1996Date of Patent: July 7, 1998Assignee: Buckman Laboratories International, Inc.Inventors: David Oppong, Russel E. Fues, Graciela H. Vunk
-
Patent number: 5767113Abstract: In accordance with the present invention, it has been discovered that certain synthetic steroid compounds are capable of inhibiting the efflux pump which is believed to be responsible for multidrug resistance, while at the same time activating glucocorticoid-induced response. Thus, chemotherapy of glucocorticoid sensitive tumors can be enhanced by use of a compound having the dual ability to activate glucocorticoid-induced response and facilitate the accumulation of drug at the target site, with reduced or eliminated competition by the drug efflux system.Type: GrantFiled: May 10, 1995Date of Patent: June 16, 1998Assignee: The Salk Institute For Biological StudiesInventors: Suzanne Bourgeois Cohn, Donald J. Gruol
-
Patent number: 5756524Abstract: A compound of formula I ##STR1## X is O or S; A is 6-alkoxy-3-pyridyl optionally substituted by halogen;Y is hydrogen or alkyl;R.sup.3 is alkyl or a metal salt complex thereof. This invention contains fungicidal compositions and are used to combat cytopathogenic fungi.Type: GrantFiled: September 18, 1996Date of Patent: May 26, 1998Assignee: Agrevo UK LimitedInventors: Peter Dominic Riordan, Susan Elizabeth Osbourn, Ian Kenneth Boddy
-
Patent number: 5728715Abstract: This invention relates to substituted dihydropyridazinones, pyridazinones and related compounds, of the formula ##STR1## wherein A, Q, D and R1 are as defined within, compositions containing these compounds and methods of controlling agricultural and mammalian fungal diseases.Type: GrantFiled: October 30, 1996Date of Patent: March 17, 1998Assignee: Rohm and Haas CompanyInventors: Enrique Luis Michelotti, Anne Ritchie Egan, Ronald Ross, Jr., Willie Joe Wilson
-
Patent number: 5681578Abstract: A composition for relieving stress, anxiety, grief, and depression includes GABA (gamma amino butyric acid), glutamine, glycine, magnesium, passion flower, primula officinalis, and vitamin B-6.Type: GrantFiled: January 22, 1996Date of Patent: October 28, 1997Inventor: Billie J. Sahley
-
Patent number: 5650095Abstract: The present invention relates to a process for producing a gel-free dispersion or solution of copper pyrithione employing at least one surfactant. Also claimed is the dispersion or solution itself, as well as a solid particulate copper pyrithione composition comprising copper pyrithione particles having a particle shape selected from the group consisting of rods, spheres, needles, platelets and combinations thereof, and optionally containing at least a trace amount of a surfactant on the outer surface of at least a portion of said particles.Type: GrantFiled: January 22, 1996Date of Patent: July 22, 1997Assignee: Olin CorporationInventors: Saeed M. Hosseini, Charles W. Kaufman, Patrick Hobbs, John J. Jardas, Murray A. Ruggiero, Shoaib Arif
-
Patent number: 5626849Abstract: The present invention involves a dietary supplement that can be used as a weight loss composition. The composition comprises of an essentially dry mixture of chromium, L-carnitine, gamma-linolenic acid, (-) hydroxycitric acid, choline, inositol, antioxidants and herbs. The preferred antioxidants are Coenzyme Q10 and the herbs are ginkgo biloba leaves. The essentially dry mixture can be prepared as a beverage and delivered enterally. The present invention also involves a method for inducing weight loss in a mammal. The method involves administering to a mammal, preferably a human, a weight loss inducing effective amount of the above described essentially dry mixture. The weight loss inducing effective amount of the above composition is administered daily in at least two separate portions of 7.325 grams each.Type: GrantFiled: June 7, 1995Date of Patent: May 6, 1997Assignee: Reliv International, Inc.Inventors: Carl W. Hastings, David J. Barnes
-
Patent number: 5614538Abstract: Disclosed herein is an antimicrobial composition characterized by synergistic antibacterial efficacy against Gram-negative bacteria and comprising an antimicrobially effective amount of a pyrithione salt or pyrithione acid, and an alcohol, preferably an aromatic alcohol. Also disclosed is a method of imparting antimicrobial activity to a composition comprising water or an organic solvent which comprises adding thereto an antimicrobially effective amount of the above-described antimicrobial composition.Type: GrantFiled: December 5, 1994Date of Patent: March 25, 1997Assignee: Olin CorporationInventor: John D. Nelson, Jr.
-
Patent number: 5612054Abstract: This invention relates to a pharmaceutical composition for treating gastrointestinal distress comprising an effective amount of an antidiarrheal composition, e.g. loperamide, and an antiflatulent effective amount of simethicone and methods of treating gastrointestinal distress comprising administering such pharmaceutical compositions.Type: GrantFiled: April 19, 1995Date of Patent: March 18, 1997Assignee: McNeil-PPC, Inc.Inventor: Jeffrey L. Garwin
-
Patent number: 5587368Abstract: A method for preventing or reducing restenosis wherein a 27-hydroxycholesterol or a 25,26 and/or 27-aminocholesterol, or a sterol 27-hydroxylase stimulant, is administered in a restenosis preventing and/or reducing amount. The invention also includes a method for treating cancer using 27-hydroxycholesterol.Type: GrantFiled: October 6, 1994Date of Patent: December 24, 1996Assignee: New York UniversityInventor: Norman B. Javitt
-
Patent number: 5582817Abstract: Zinc salts, zinc complexes or salts thereof of a compound selected from the group consisting of nicotinamides, picolinamides, 3,4-dihydroxybenzoic acids, amino acids, peptides, hinokitiols and pyridine carboxylic acids represented by formula (1): ##STR1## possess a metallothionein inducing effect, effect of suppressing the production of sunburn cells, and therefore, useful as cosmetics and as drugs which are for ameliorating sunburn, preventing sunburn, ameliorating skin diseases, relieving irradiation disorders, and the like.Type: GrantFiled: October 1, 1993Date of Patent: December 10, 1996Assignees: Otsuka Pharmaceutical Co., Ltd., Japan Immunoresearch Laboratories Co., Ltd.Inventors: Yoshiro Otsu, Yaeno Arima, Katsuyuki Nakajima, Masakazu Adachi, Tsutomu Muramatsu, Katsumi Hanada
-
Patent number: 5543405Abstract: A weight reduction composition comprises a sympathomimetic agent and a mineral cation salt or chelate capable of enhancing carbohydrate metabolism, protein or fatty acid synthesis, retarding protein breakdown or lowering serum cholesterol levels such as trivalent and hexavalent chromium and vanadium salts and chelates. Preferred is a weight reduction composition containing ephedrine and chromium picolinate. This composition is presented in a variety of formulations, and is suitable for application to the reduction of weight of normal, slightly and grossly overweight humans.Type: GrantFiled: October 20, 1994Date of Patent: August 6, 1996Inventors: Wendy J. Keown, Betty J. Ford, Sandra L. Stoddard
-
Patent number: 5540860Abstract: The present invention relates to a process for producing a gel-free dispersion or solution of copper pyrithione employing at least one surfactant. Also claimed is the dispersion or solution itself, as well as a solid particulate copper pyrithione composition comprising copper pyrithione particles having a particle shape selected from the group consisting of rods, spheres, needles, platelets and combinations thereof, and optionally containing at least a trace amount of a surfactant on the outer surface of at least a portion of said particles.Type: GrantFiled: February 28, 1994Date of Patent: July 30, 1996Assignee: Olin CorporationInventors: Saeed M. Hosseini, Charles W. Kaufman, Patrick Hobbs, John J. Jardas, Murray A. Ruggiero, Shoaib Arif
-
Patent number: 5521171Abstract: Disclosed herein are anti-inflammatory and anti-ulcer copper coordination compounds and a process for using them in the treatment of arthritis and gastrointestinal ulcers in animal bodies. The copper coordination compounds utilized are the reaction products of copper salts with:1. aromatic carboxylic acids or their alkaline earth salts;2. heterocyclic carboxylic acids or their alkaline earth salts;3. amino acids or their alkaline earth salts;4. amines; and5. suitably substituted steroids.The process disclosed comprises administering to experimental animals, orally or parentrally (subcutaneously), in controlled dosages, the aforementioned copper coordination compounds for the treatment of inflammation (i.e., arthritis) and ulcers of the gastrointestinal tract.Type: GrantFiled: March 24, 1995Date of Patent: May 28, 1996Inventor: John R. J. Sorenson
-
Patent number: 5489584Abstract: Compounds of the formula ##STR1## having retinoid like biological activity.Type: GrantFiled: December 29, 1994Date of Patent: February 6, 1996Assignee: Allergan, Inc.Inventors: Vidyasagar Vuligonda, Richard L. Beard, Roshantha A. Chandraratna
-
Patent number: 5451577Abstract: A composition which contains a 4,5-polymethylene-4-isothiazolin-3-one and a salt or complex of 2-mercaptopyridine-1-oxide with a metal which is at least divalent. The salt or complex is typically zinc 2-thiopyridine-1-oxide. The compositions exhibit anti-microbial activity and certain combinations of isothiazolinones together with zinc 2-thiopyridine-1-oxide are surprisingly effective against both bacteria and fungi.Type: GrantFiled: September 3, 1993Date of Patent: September 19, 1995Assignee: Zeneca LimitedInventor: Fraser F. Morpeth
-
Patent number: 5409915Abstract: Novel bis(platinum) (IV) complexes coupled via diamine bridging agents are taught as well as methods for their preparation. These complexes are to be used as pharmaceutical agents, e.g., for the treatment of cancer and parasitic diseases.Type: GrantFiled: September 14, 1993Date of Patent: April 25, 1995Assignee: The University of Vermont and State Agricultural CollegeInventors: Nicholas Farrell, Silvano Spinelli, Mariella Valsecchi, Ernesto Menta
-
Patent number: 5409914Abstract: The present invention provides a pharmaceutical composition of a complex compound having the structure: ##STR1## wherein R.sub.1 and R.sub.1, are the same or different and each is an alkyl group, a phenyl group or a substituted derivative of a phenyl group;wherein R.sub.2 and R.sub.2, are the same or different and each is hydrogen, an unbranched alkyl group, a halide or a group having the structure ##STR2## wherein R is hydrogen, an alkoxide group, an alkyl group, or OH; wherein R.sub.3 and R.sub.3, are the same or different and each is hydrogen or an alkyl group;wherein X and X' are the same or different and each is a water soluble group having weak to intermediate ligand field strength; andQ is a soluble, pharmaceutically acceptable negative ion.Type: GrantFiled: November 1, 1993Date of Patent: April 25, 1995Assignee: Chai-Tech CorporationInventors: Zvi Dori, David Gershon
-
Patent number: 5407688Abstract: The present invention relates to pharmaceutical compositions useful for treating or preventing gastrointestinal disorders. These compositions comprise a campylobacter-inhibiting antimicrobial agent such as nitrofurantoin and bismuth subsalicylate, and a histamine-2 receptor blocking anti-secretory agent such as cimetidine.The present invention further relates to methods for treating or preventing gastrointestinal disorders in humans or lower animals by administering a campylobacter-inhibiting antimicrobial agent and a histamine-2 receptor blocking anti-secretory agent.Type: GrantFiled: October 30, 1992Date of Patent: April 18, 1995Assignee: The Procter & Gamble CompanyInventor: Geoffrey Place
-
Patent number: 5403830Abstract: The present invention relates to pharmaceutical compositions useful for treating or preventing gastrointestinal disorders. These compositions comprise a bismuth-containing agent, preferably a campylobacter-inhibiting bismuth-containing agent such as bismuth subsalicylate and bismuth subcitrate, and a histamine-2 receptor blocking anti-secretory agent such as cimetidine.The present invention further relates to methods for treating or preventing gastrointestinal disorders in humans or lower animals by administering a bismuth-containing agent and a histamine-2 receptor blocking anti-secretory agent.Type: GrantFiled: January 10, 1992Date of Patent: April 4, 1995Assignee: The Proctor & Gamble CompanyInventor: Geoffrey Place
-
Patent number: 5384108Abstract: Novel magnetic resonance imaging agents comprise complexes of paramagnetic ions with hydrazide derivatives of polyaminocarboxylic acid chelating agents. The complexes are represented by the formula of: ##STR1## wherein A is --CHR.sup.2 --CHR.sup.3 -- or ##STR2## M.sup.+Z is a paramagnetic ion of an element with an atomic number of 21-29, 42-44 58-70, and a valence, Z, of +2 or +3; R.sup.1 groups may be the same or different and are selected from the group consisting of --O.sup.- and ##STR3## The R.sup.4, R.sup.5 and R.sup.6 groups are as defined in the disclosure. These novel imaging agents are characterized by excellent NMR image-contrasting properties and by high solubilities in physiological solutions. A novel method of performing an NMR diagnostic procedure involves administering to a warm-blooded animal an effective amount of a complex as described above and then exposing the warm-blooded animal to an NMR imaging procedure, thereby imaging at least a portion of the body of the warm-blooded animal.Type: GrantFiled: April 24, 1989Date of Patent: January 24, 1995Assignee: Mallinckrodt Medical, Inc.Inventor: Raghavan Rajagopalan
-
Patent number: 5384114Abstract: An opacifier comprising an amine including at least one carbon chain of at least 16 carbon atoms or a fatty amidoamine having an alkyl group including at least about thirteen carbon atoms, and a suitable acid is disclosed. The opacifier is a salt of the long-chain amine and effectively opacifies, or pearlizes, water-based compositions, such as hair treating compositions, like shampoos, conditioners, conditioning shampoos and antidandruff shampoos; and skin treating compositions, like conditioners, moisturizers and topical medicaments.Type: GrantFiled: July 23, 1993Date of Patent: January 24, 1995Assignee: Helene Curtis, Inc.Inventors: Teresa J. Dowell, Gerald P. Newell, Eugene Zeffren
-
Patent number: 5336672Abstract: Egg production in poultry can be increased by the administration of chromium picolinate, preferably as a feed additive. The amounts of chromium picolinate required are low, so this method of increasing egg production can be administered both easily and economically.Type: GrantFiled: July 21, 1992Date of Patent: August 9, 1994Assignee: Board of Supervisors of Louisiana State University and Agricultural and Mechanical CollegeInventors: Lincoln L. Southern, Jr., Timothy G. Page
-
Patent number: 5332579Abstract: A nutritional supplement, functioning as a food for special dietary use, enhances diets and assists persons recovering from addiction to health damaging substances. Since cellular damage and deficiencies occur and continue to exist even after the person has stopped abusing the substances, use of the nutritional supplement, which contains a variety of minerals, vitamins, herbs, amino acids, and other substances and nutrients, should be continuous. The nutritional supplement consists of a mixture of nutrients which cooperate synergistically in enhancing cellular metabolic pathways and assists in normalization of cellular functions and optimization of cellular health.Type: GrantFiled: November 20, 1992Date of Patent: July 26, 1994Inventor: Anthony J. Umbdenstock
-
Patent number: 5318962Abstract: Water-soluble complexes having the formula: ##STR1## and stereoisomers thereof, where Z.sup.1 and Z.sup.2 are halogens, and X.sup.1 and X.sup.2 are selected from the group consisting of sulfate, phosphate, nitrate, and monocarboxylate, or are jointly dicarboxylate, have been found to have desirable antitumor activity, as well as relatively low levels of toxicity.Type: GrantFiled: August 7, 1992Date of Patent: June 7, 1994Assignee: Board of Regents, The University of Texas SystemInventors: Abdul R. Khokhar, Zahid H. Siddik, Robert A. Newman
-
Patent number: 5308627Abstract: A nutritional supplement, functioning as a food for special dietary use, enhances diets and assists persons recovering from addiction to health damaging substance(s). Since cellular damage and deficiencies occur and continue to exist even after the person has stopped abusing the substance(s), use of the nutritional supplement, which contains at least one enzyme activating substance and at least one enzyme cofactor, should be continuous. The nutritional supplement consists of a mixture of nutrients which cooperate synergistically in enhancing cellular metabolic pathways and assists in normalization of cellular functions and optimization of cellular health.Type: GrantFiled: November 19, 1992Date of Patent: May 3, 1994Inventor: Anthony J. Umbdenstock, Jr.
-
Patent number: 5298061Abstract: The present invention relates generally to paints and paint bases, and, more specifically to a process and composition for providing a stable gel-free dispersion of zinc pyrithione plus cuprous oxide biocide in paint. In accordance with the process of the present invention, the paint or paint base contains an amine treated wood rosin in order to impart desired gelation-inhibition to the paint.Type: GrantFiled: May 14, 1993Date of Patent: March 29, 1994Assignee: Olin CorporationInventors: Craig Waldron, Douglas A. Farmer, Jr., Rahim Hani
-
Patent number: 5292729Abstract: Vitamin and mineral absorption in warm-blooded animals is promoted by means of a class of vitamin chelates where at least one of the bonds between the metal ion and the vitamin ligand is formed between the ion and an electron rich .pi.-cloud of an aromatic ring of the water soluble vitamin. The chelate, containing a total of from one to three ligands, may contain from one up to three vitamin ligands which form a .pi.-bond with the mineral and, when present, one or two amino acid, dipeptide or tripeptide ligands. The mineral is selected from the group consisting of Fe, Cu, Zn, Mg, Mn and Ca. The water soluble vitamin ligand is preferably a residue of nicotinamide, nicotinic acid, pyridoxine, thiamine, riboflavin and folic acid. The amino acid may be any of the naturally occurring .alpha.-amino acids such as glycine. The .pi.-bond vitamin chelates are absorbed more readily from both the gastric and intestinal areas of the GI tract than vitamins or minerals administered separately or as mixtures.Type: GrantFiled: August 14, 1992Date of Patent: March 8, 1994Assignee: Albion International, Inc.Inventor: Harvey H. Ashmead
-
Patent number: 5284649Abstract: Deodorant gel stick compositions, which are essentially free of water, comprising a heavy metal salt of 1-hydroxy pyridinethione as the deodorant active, a gelling agent, and a solvent system (preferably a polar solvent) are disclosed. These compositions have minimized component interactions, active component stability, and are excellent in the prevention of body malodors. Preferred compositions utilize zinc pyrithione as the deodorant active, and contain less than about 1% water. Other standard deodorant components may be included in compositions for cosmetic purposes.Type: GrantFiled: September 29, 1992Date of Patent: February 8, 1994Assignee: The Procter & Gamble CompanyInventor: Prem S. Juneja
-
Patent number: 5278154Abstract: Compounds of formula (I): ##STR1## in which: R.sub.1 or R.sub.4, which are identical or different, represent hydrogen or alkyl,R.sub.2 represents hydrogenm or alkyl, hydroxymethyl, --CH.sub.2 OPO(OH).sub.2 or --CH.sub.2 OPO(ONa).sub.2,R.sub.3 represents hydrogen, alkyl or hydroxyl or any one of the following groups: ##STR2## in which: T represents oxygen or sulfur,n represents an integer between 1 and 4,R.sub.5 represents hydrogen or alkyl,X represents nitrogen, CH or CR'.sub.3 (in which R'.sub.3 has the same meaning as R.sub.3 except in the case where R.sub.3 represents hydroxyl),A represents alkylene of formula --(CH.sub.2).sub.p --in which p represents an integer between 2 and 4, optionally substituted by one or more linear or branched (C.sub.1 -C.sub.Type: GrantFiled: December 31, 1992Date of Patent: January 11, 1994Assignee: Adir et CompagnieInventors: Jean-Michel Lacoste, Jacques Duhault, Denis Ravel
-
Patent number: 5266560Abstract: A composition of matter having GTF-like activity, its preparation and its use in treating chromium deficiency and insulin resistance diseases such as diabetes are set forth. The composition comprises: ##STR1## m=1, 2 or 3; n=0, 1 or 2; p=0, 1, 2, 3, 4 or 5; q=0, 1, 2, 3, 4 or 5; r=0, 1, 2 or 3;m+2n+p+q+r.ltoreq.6;if p and q both=0, n=1 pr z;if n=0, p and/or q.noteq.0;including mixtures and oligomers thereof, wherein:each R.sup.1 is independently selected from hydrogen, C.sub.1-3 alkyl, C.sub.2-3 alkenyl and C.sub.2-3 alkynyl, or two R.sup.1 form a ring having, including the N atom to which they are attached, 5 to 7 ring atoms;each R.sup.2 is independently selected from hydrogen, C.sub.1-4 alkyl, C.sub.2-4 alkenyl and C.sub.2-4 alkynyl or two adjacent R.sup.1 and R.sup.2 form a ring having, including the N and C atoms to which they are attached, 5 to 7 ring atoms;each R.sup.3 is independently selected from hydrogen, fluoro, chloro, bromo, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl, COOH, COOR.sup.Type: GrantFiled: September 9, 1991Date of Patent: November 30, 1993Assignee: Thomas Research CorporationInventors: Sydney C. Furman, Charles T. Goetschel, Branko Huc, Thomas H. Nufert
-
Patent number: 5258403Abstract: The present invention provides pharmaceutical compositions for the treatment of tumor cells in a subject of for the treating of undesirable symptoms associated with the presence of free radicals. The compositions comprising a complex compound having the structure: ##STR1## wherein R.sub.1 and R.sub.1, are the same or different and each is an alkyl group, a phenyl group or a substituted derivative of a phenyl group;wherein R.sub.2 and R.sub.2, are the same or different and each is hydrogen, an unbranched alkyl group, a halide or a group having the structure ##STR2## wherein R is hydrogen, an alkoxide group, an alkyl group, or OH; wherein R.sub.3 and R.sub.3, are the same or different and each is hydrogen or an alkyl group;wherein X and X' are the same or different and each is a water soluble group having weak to intermediate ligand field strength; andQ is a soluble, pharmaceutically acceptable negative ion and a pharmaceutically acceptable carrier.Type: GrantFiled: June 2, 1992Date of Patent: November 2, 1993Assignee: Chai-Tech CorporationInventors: Zvi Dori, David Gershon
-
Patent number: 5252123Abstract: The present invention relates generally to paints and paint bases, and, more specifically to a process for providing a stable gel-free dispersion of biocidal amounts of 2,2'-dithiobis(pyridine-1-oxide) or its metal salt adducts of the formula (C.sub.5 H.sub.4 NOS).sub.2 MY.sub.t or their hydrates plus cuprous oxide biocide in paint, where M is an alkaline earth metal, Y is the anion of an organic or inorganic acid, and t is 1 or 2. The resulting paint is storage stable and remains gel-free after several months of storage at room temperature.Type: GrantFiled: January 4, 1993Date of Patent: October 12, 1993Assignee: Olin CorporationInventors: Rahim Hani, Craig Waldron, Douglas A. Farmer, Jr.
-
Patent number: 5248505Abstract: This invention relates to a pharmaceutical composition for treating gastrointestinal distress comprising an effective amount of an antidiarrheal composition, e.g. loperamide, and an antiflatulent effective amount of simethicone and methods of treating gastrointestinal distress comprising administering such pharmaceutical compositions.Type: GrantFiled: March 17, 1992Date of Patent: September 28, 1993Assignee: McNeil-PPC, Inc.Inventor: Jeffrey L. Garwin
-
Patent number: 5238490Abstract: The present invention relates generally to paints and paint bases, and, more specifically to a process for providing in situ generation of copper pyrithione biocide in a paint or paint base which comprises incorporating a compound of pyrithione, cuprous oxide and a controlled amount of water into the paint or paint base either during or after formulation of the paint or paint base.Type: GrantFiled: March 1, 1993Date of Patent: August 24, 1993Assignee: Olin CorporationInventors: Douglas A. Farmer, Jr., Rahim Hani, Craig Waldron
-
Patent number: 5232493Abstract: The present invention relates generally to paints and paint bases, and, more specifically to a process and composition for providing a stable gel-free dispersion of zinc pyrithione plus cuprous oxide biocide in paint. In accordance with the process of the present invention, the paint or paint base is essentially water-free, and preferably contains a desiccant in order to impart desired gelation-inhibition to the paint.Type: GrantFiled: September 1, 1992Date of Patent: August 3, 1993Assignee: Olin CorporationInventors: Craig Waldron, Rahim Hani, Douglas A. Farmer, Jr., Charles E. Branch
-
Patent number: 5219847Abstract: An antipruritic composition for an oral medicine, injection, and external medicine, comprising an effective amount of a chelated zinc (e.g., zinc picolinate) as an antipruritic agent.Type: GrantFiled: July 27, 1992Date of Patent: June 15, 1993Assignee: Shiseido Company, Ltd.Inventors: Shigeru Taguchi, Takashi Suzuki, Chikao Nishino, Yoshimori Fujinuma, Chuji Yanagawa, Michihiro Yamaguchi, Miwako Yamato, Noriko Nakajima, Mie Kitano, Tomomi Okazaki, Masaki Uemura, Ryuhei Inada, Yoshiko Tonomura
-
Patent number: 5196412Abstract: The present invention relates to compounds of gallium (III) which can be given orally to achieve high serum levels of gallium (III) for the treatment of hypercalcemia of malignancy and related disorders of bone metabolism. Complexes of gallium (III) of the formula (I) ##STR1## wherein R.sub.1 is C.sub.1 -C.sub.8 n-alkyl and R.sub.2 is H or C.sub.1 -C.sub.2 alkyl, or R.sub.1 and R.sub.2 together form tetra- or penta-methylene and wherein said complex is useful in increasing calcium content of bone tissue and decreasing bone resorption, are used in an amount sufficient to cause an increase in calcium content of said bone and to cause decreased bone resorption.Type: GrantFiled: March 6, 1991Date of Patent: March 23, 1993Assignee: Johnson Matthey, Inc.Inventors: Fontaine C. Bradley, Chris M. Giandomenico, Michael J. Abrams, Danielle T. Frost, Jean F. Vollano
-
Patent number: 5185033Abstract: The present invention relates generally to paints and paint bases, and, more specifically to a process for providing a stable gel-free dispersion of copper pyrithione or pyrithione disulfide plus cuprous oxide biocide in paint. The resulting paint is storage stable and remains gel-free after several months of storage at room temperature.Type: GrantFiled: September 1, 1992Date of Patent: February 9, 1993Assignee: Olin CorporationInventors: Rahim Hani, Craig Waldron, Douglas A. Farmer, Jr.
-
Patent number: 5177068Abstract: Iron complexes comprising a ferric cation in combination with at least two different ligands, at least one of which is provided by a compound being:(1) 3-hydroxy-4-pyrone or a 3-hydroxy-4-pyrone in which one or more of the hydrogen atoms attached to ring carbon atoms are replaced by an aliphatic hydrocarbon group of 1 to 6 carbon atoms; or(2) a 3-hydroxypyrid-2-one or 3-hydroxypyrid-4-one in which the hydrogen atom attached to the nitrogen atom is replaced by an aliphatic acyl group, by an aliphatic hydrocarbon group of 1 to 6 carbon atoms, or by an aliphatic hydrocarbon group substituted by one or more substituents selected from aliphatic acyl, alkoxy, alphatic amide, aliphatic ester, halogen and hydroxy groups and, optionally, in which one or more of the hydrogen atoms attached to ring carbon atoms are replaced by one of said substituents, by an aliphatic hydrocarbon group of 1 to 6 carbon atoms, or by an aliphatic hydrocarbon group substituted by an alkoxy, aliphatic ester, halogen or hydroxy group; the chType: GrantFiled: May 8, 1989Date of Patent: January 5, 1993Assignee: National Research Development CorporationInventors: Brian A. Callingham, Robert C. Hider, George Kontoghiorghes, Michael A. Stockham
-
Patent number: 5175156Abstract: The administration of chromic picolinate, preferably in the form of chromic tripicolinate, as a prophylactic or therapeutic agent for controlling various blood serum parameters. In particular, the administration is for controlling blood serum lipid levels, including the lowering of undesirably high blood serum LDL-cholesterol levels and the raising of blood serum HDL-cholesterol levels. Additionally, the administration is for controlling undesirable high blood serum glucose levels, this being particularly applicable for the treatment of maturity-onset diabetes. Additionally, chromic picolinate, preferably in the form of chromic tripicolinate, is administered to facilitate uptake of amino acids by skeletal muscle. Thus chromic picolinate can act as an effective anabolic agent.Type: GrantFiled: December 9, 1991Date of Patent: December 29, 1992Assignee: Nutrition 21Inventors: Herb Boynton, Gary W. Evans
-
Patent number: 5164384Abstract: The present invention is an ergogenic, anabolic mineral formula for use as a nutritional supplement, weight loss formula and cholesterol lowering agent. The formula comprises 500 mcg. of vanadyl sulfate, 100 mcg. of chromium picolinate, 100 mcg. of chromium nicotinate glycinate, and 25 mg. of niacin. The vanadyl sulfate and chromium components are used primarily to mimic and enhance the effects of insulin. The niacin component is included to cause blood vessels to dilate and to reduce cholesterol levels and thus improve the efficiency of chromium and carbohydrate utilization.Type: GrantFiled: June 19, 1991Date of Patent: November 17, 1992Assignee: Metagenics, Inc.Inventor: Steven M. Paul
-
Patent number: RE34313Abstract: Compounds which are a 1-hydroxypyrid-2-one in which one or more of the hydrogen atoms attached to ring carbon atoms are replaced by a substituent selected from aliphatic acyl, aliphatic amide, aliphatic amine, carboxy, cyano, aliphatic ester, halogen, hydroxy and sulpho groups, alkoxy groups and alkoxy groups substituted by an alkoxy, aliphatic amide, aliphatic amine, aliphatic ester, halogen or hydroxy group, aliphatic hydrocarbon groups and aliphatic hydrocarbon groups substituted by an alkoxy, aliphatic ester, halogen or hydroxy group, but excluding compounds in which said replacement of hydrogen atoms in the compound is effected only by substituents selected from aliphatic hydrocarbon groups, halogen groups and aliphatic hydrocarbon groups substituted by a halogen group, or a salt thereof containing a physiolgically acceptable ion or ions, are of value in the treatment of patients having a toxic concentration of a metal, particularly iron, in the body whilst the iron complexes of such compounds are of valType: GrantFiled: October 1, 1991Date of Patent: July 13, 1993Assignee: National Research Development CorporationInventors: Robert C. Hider, George Kontoghiorghes, Jack Silver, Michael A. Stockham